Transcription factor AP-2β inhibits expression and secretion of leptin, an insulin-sensitizing hormone, in 3T3-L1 adipocytes
Transcription factor AP-2β inhibits expression and secretion of leptin, an insulin-sensitizing hormone, in 3T3-L1 adipocytes
复制标题
DOI:
10.1038/ijo.2009.295
复制
发表时间:
2010-04-01
影响因子:
4.9
通讯作者:
Maegawa, H.
中科院分区:
文献类型:
--
作者:
Fuke, T.;Yoshizaki, T.;Maegawa, H.
Background: We have previously reported an association between the activator protein-2 beta (AP-2 beta) transcription factor gene and type 2 diabetes. This gene is preferentially expressed in adipose tissue, and subjects with a disease-susceptible allele of AP-2 beta showed stronger AP-2 beta expression in adipose tissue than those without the susceptible allele. Furthermore, overexpression of AP-2b led to lipid accumulation and induced insulin resistance in 3T3-L1 adipocytes.Result: We found that overexpression of AP-2 beta in 3T3-L1 adipocytes decreased the promoter activity of leptin, and subsequently decreased both messenger RNA (mRNA) and protein expression and secretion. Furthermore, knockdown of endogenous AP-2 beta by RNA-interference increased mRNA and protein expression of leptin. Electrophoretic mobility shift and chromatin immunoprecipitation assays revealed specific binding of AP-2 beta to leptin promoter regions in vitro and in vivo. In addition, site-directed mutagenesis of the AP-2-binding site located between position | 34 and | 42 relative to the transcription start site abolished the inhibitory effect of AP-2 beta. Our results clearly showed that AP-2 beta directly inhibited insulin-sensitizing hormone leptin expression by binding to its promoter.Conclusion: AP-2 beta modulated the expression of leptin through direct interaction with its promoter region. International Journal of Obesity (2010) 34, 670-678; doi: 10.1038/ijo.2009.295; published online 12 January 2010